MACROGENICS, INC. Public Float
MACROGENICS, INC. (MGNX) had Public Float of $73.90 million as of 2025-06-30, per its 10-K filed 2026-03-09.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-09
- 2025-06-30: Entity Public Float $73.90M.
- 2024-06-28: Entity Public Float $259.40M.
- 2023-12-31: Entity Public Float $322.50M.
- 2022-12-31: Entity Public Float $181.30M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $73.90M 10-K · filed 2026-03-09 |
| 2024-06-28 | $259.40M 10-K · filed 2025-03-20 |
| 2023-12-31 | $322.50M 10-K · filed 2024-03-07 |
| 2022-12-31 | $181.30M 10-K · filed 2023-03-15 |
| 2021-12-31 | $1.60B 10-K · filed 2022-02-24 |
| 2020-06-30 | $1.50B 10-K · filed 2021-02-25 |
| 2019-06-28 | $829.70M 10-K/A · filed 2020-03-02 |
| 2018-06-29 | $842.50M 10-K · filed 2019-02-26 |
| 2017-06-30 | $936.00M 10-K · filed 2018-02-27 |
| 2016-06-30 | $936.00M 10-K · filed 2017-02-28 |
| 2015-06-30 | $1.05B 10-K · filed 2016-02-29 |
| 2014-06-30 | $437.21M 10-K · filed 2015-03-03 |
| 2014-02-28 | $698.02M 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |